Empagliflozin alleviates diabetic cardiomyopathy via inhibiting excessive autophagy and adverse remodeling in type 1 diabetic mice

Saved in:
Bibliographic Details
Published in:European heart journal 2022-10, Vol.43 (Supplement_2)
Main Authors: Madonna, R, Moscato, S, Cufaro, M, Pieragostino, D, Mattii, L, Del Boccio, P, Ghelardoni, S, Zucchi, R, De Caterina, R
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehac544.2989